Dr. Bert Grobben is a Global Open Innovation leader, a strategic foresight expert, a serial Entrepreneur, and an Ironman Triathlete. He is passionate about Healthy living, preventative Health and Sustainability. His extensive experience with both Multinational Corporates and Early-Stage Startups makes him particularly well-suited to build ecosystems where early-stage Deeptech can make its way into a Corporate portfolio. He has >25-year innovation track record leading >$100M program portfolios as a corporate leader (P&G, Avery Dennison) and as a venture builder in implementing sustaining & disrupting innovations for Billion-dollar Brands. He has extensive experience running global programs, and deep cross-regional exposure. He operates seamlessly across cultures, and both technical and business domains. A unique skill is his background in qualitative Consumer & Market Insight. He focuses on identifying and translating key Consumer & Brand experiences and un-met needs into growth & expansion opportunities. His broad cross-industry exposure allows him to support Brands on their business model innovation, and identify new opportunities for profitable growth and geographical expansion. As a Biomedical PhD, and an innovation track record across Health related domains, he is now also supporting SMEs and Startups on early stage business model innovation, defining and optimising product-market-fit and go-to-market strategy and designing product experiences that address critical needs and winning in-use experiences. As a master in the process of executing innovation processes, he works with companies as a venture builder, a CxO, an advisor or as a consultant to ensure innovative products get implemented into the business and the markets. Dr. Bert Grobben is a Global Open Innovation leader, a strategic foresight expert, a serial Entrepreneur, and an Ironman Triathlete. He is passionate about Healthy living, preventative Health and Sustainability. His extensive experience with both Multinational Corporates and Early-Stage Startups makes him particularly well-suited to build ecosystems where early-stage Deeptech can make its way into a Corporate portfolio. He has >25-year innovation track record leading >$100M program portfolios as a corporate leader (P&G, Avery Dennison) and as a venture builder in implementing sustaining & disrupting innovations for Billion-dollar Brands. He has extensive experience running global programs, and deep cross-regional exposure. He operates seamlessly across cultures, and both technical and business domains. A unique skill is his background in qualitative Consumer & Market Insight. He focuses on identifying and translating key Consumer & Brand experiences and un-met needs into growth & expansion opportunities. His broad cross-industry exposure allows him to support Brands on their business model innovation, and identify new opportunities for profitable growth and geographical expansion. As a Biomedical PhD, and an innovation track record across Health related domains, he is now also supporting SMEs and Startups on early stage business model innovation, defining and optimising product-market-fit and go-to-market strategy and designing product experiences that address critical needs and winning in-use experiences. As a master in the process of executing innovation processes, he works with companies as a venture builder, a CxO, an advisor or as a consultant to ensure innovative products get implemented into the business and the markets.

• 

  Business development, product innovation, go-to-market strategy advisor in Greenitio

  We believe in nature leading the way